Literature DB >> 3083885

Bone marrow transplantation in Hunter syndrome: a preliminary report.

P I Warkentin, M S Dixon, I Schafer, S E Strandjord, P F Coccia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3083885

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN： 0547-6844


× No keyword cloud information.
  10 in total

Review 1.  Displacement bone marrow transplantation for some inborn errors.

Authors:  J R Hobbs
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice.

Authors:  Yasuyuki Fujita; Riichiro Abe; Daisuke Inokuma; Mikako Sasaki; Daichi Hoshina; Ken Natsuga; Wataru Nishie; James R McMillan; Hideki Nakamura; Tadamichi Shimizu; Masashi Akiyama; Daisuke Sawamura; Hiroshi Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 3.  Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?

Authors:  Claire Horgan; Simon A Jones; Brian W Bigger; Robert Wynn
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).

Authors:  P L Crotty; C B Whitley
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

5.  Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse.

Authors:  P M Hoogerbrugge; B J Poorthuis; A E Romme; J J van de Kamp; G Wagemaker; D W van Bekkum
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.

Authors:  S E Braun; E L Aronovich; R A Anderson; P L Crotty; R S McIvor; C B Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.

Authors:  Francyne Kubaski; Hiromasa Yabe; Yasuyuki Suzuki; Toshiyuki Seto; Takashi Hamazaki; Robert W Mason; Li Xie; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal; Roberto Giugliani; Vũ Chí Dũng; Can Thi Bich Ngoc; Seiji Yamaguchi; Adriana M Montaño; Kenji E Orii; Toshiyuki Fukao; Haruo Shintaku; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-01       Impact factor: 5.742

Review 8.  Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.

Authors:  Kazuki Sawamoto; Molly Stapleton; Carlos J Alméciga-Díaz; Angela J Espejo-Mojica; Juan Camilo Losada; Diego A Suarez; Shunji Tomatsu
Journal:  Drugs       Date:  2019-07       Impact factor: 11.431

Review 9.  Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II.

Authors:  Koji Matsuhisa; Kazunori Imaizumi
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

10.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.